Skip to content
DraconiticResearch
Search Sources API
220,788 studies31 sourcesUpdated 11 min ago
Peer-reviewedCC BYThe Journal of infectious diseases

Risk maps and spatial models for clinical infectious disease decision-making

  • Seth D. Judson1
  1. 1Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, California, USA
Read full textPDFDOICite

Abstract

Risk maps and spatial models provide key information about the endemicity and spread of infectious diseases. Novel data streams and statistical techniques, with the aid of artificial intelligence, create the opportunity for modern risk maps. To ensure that these tools are useful for clinical decision-making, we need to understand how risk maps are used, how they are developed, and how they can be improved. This will be especially important for zoonotic, vector-borne, and environmental infectious diseases in the era of environmental change and globalization.

Related

  1. Communication and shared decision‐making for anti‐amyloid therapy in early Alzheimer's disease: An exploratory qualitative study of real‐world audio‐recorded clinical encounters
    Joanna Paladino, Haley Echols, Ayush Thacker +7
    Alzheimer's & Dementia : Translational Research & Clinical InterventionsPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicinePMC
  2. Quality of Movement Assessment after ACL Reconstruction in Youth: A Clinical Framework to Guide Rehabilitation and Return-to-Sport Decision-Making
    International journal of sports physical therapyPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  3. Beyond the Sagittal Plane: The Lateral Countermovement Jump as a Clinical Tool for Return-to-Play Decision-Making and Performance Evaluation
    International journal of sports physical therapyPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  4. Reliable Detection, Unreliable Clinical Decision-making: Artificial Intelligence Models in Burn Assessment
    Ibrahim Güler, Uzay Cambaz, Armin Kraus +2
    Plastic and reconstructive surgery. Global openPeer-reviewedCC BY-NC-NDFull textSurgery & anaesthesiaEurope PMC
  5. Procalcitonin-Guided Antimicrobial Therapy: Current Evidence for Clinical Decision-Making and Practical Limitations
    Sumayyah Alshammari, Basmah Alrawaili, Roaa Alshammari +4
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{judson2026risk,
  title = {{Risk maps and spatial models for clinical infectious disease decision-making}},
  author = {Seth D. Judson},
  journal = {The Journal of infectious diseases},
  year = {2026},
  month = sep,
  doi = {10.1093/infdis/jiag480},
  url = {https://doi.org/10.1093/infdis/jiag480},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Risk maps and spatial models for clinical infectious disease decision-making
AU  - Seth D. Judson
PY  - 2026
DA  - 2026/09/26
JO  - The Journal of infectious diseases
DO  - 10.1093/infdis/jiag480
UR  - https://doi.org/10.1093/infdis/jiag480
AB  - Risk maps and spatial models provide key information about the endemicity and spread of infectious diseases. Novel data streams and statistical techniques, with the aid of artificial intelligence, create the opportunity for modern risk maps. To ensure that these tools are useful for clinical decision-making, we need to understand how risk maps are used, how they are developed, and how they can be improved. This will be especially important for zoonotic, vector-borne, and environmental infectious diseases in the era of environmental change and globalization.
SN  - 0022-1899
SN  - 1537-6613
ER  -